Anti-Human ERBB3 Recombinant Antibody(Duligotuzumab)
-
产品编号
YR1277
-
别名
科研级 Duligotuzumab ( 度戈妥珠单抗 ), Anti-ERBB3 Recombinant Antibody, Research Grade Duligotuzumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Duligotuzumab ( 度戈妥珠单抗 ), Anti-ERBB3 Recombinant Antibody, Research Grade Duligotuzumab |
Catalog Number | YR1277 |
Molecular Name | Duligotuzumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Duligotuzumab (INN) is a humanized IgG1 monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER3. It is in development by Roche. Clinical development for head and neck cancer and colorectal cancer have been discontinued, but phase I trials in combination with cobimetinib are evaluating safety for treatment of solid tumors. |
CAS Number | 1314238-96-4 |
Application | FCM, IP, ELISA, Neut, FuncS, IF, WB |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | ERBB3[Homo sapiens] |